History of Esbriet (pirfenidone)

Marta Ribeiro avatar

by Marta Ribeiro |

Share this article:

Share article via email

PF_history esbriet

While the therapy was approved for use in 2014 in the US, Japan was the first country to approve its commercial use in 2008, followed by India in 2010, Europe in 2011, and China in 2013. Because IPF is considered a rare condition, this drug was designated as an ‘orphan drug’ in 2004.

Learn more: http://bit.ly/Esbriet

Print This Page

About the Author

Marta Ribeiro avatar
Marta Ribeiro Marta graduated from Universidade Fernando Pessoa in Porto with a degree in Communication Sciences and a Masters degree in New Communication Technologies. She has experience in social media, worked with several media channels, and has also worked as a freelance photographer and a graphic artist for almost 10 years.

Tags

Esbriet, pirfenidone, pulmonary fibrosis

Your PF Community

Woman laying down reading

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

View Forums

Recent Posts


Recommended reading